TransMedics Group Inc is trading 4.9% up at $74.65 as the stock extends its recent rebound amid a broader market shift back into growth names.
- The move follows a 2.5% recovery on June 8, with the stock now climbing steadily off its late-May lows to reinforce a short-term uptrend.
- The rally appears driven by a tech-led bounce in U.S. equities rather than company-specific news or fresh ratings actions.
- Current price action suggests a reversal of a prior pullback as investors rotate back into high-growth equities.